Home
Conditions
Minimal Residual Disease

Clinical trial condition

Minimal Residual Disease

Explore clinical trials studying Minimal Residual Disease. Study availability and eligibility vary by location and protocol.

49 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Minimal Residual Disease trial results

Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions: Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations: The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States

Moffitt Cancer Center Tampa, Florida, United States

The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States

View Trial Details

Recruiting

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NCT06287814

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +17 more
Locations: CHU de Montpellier Montpellier, Hérault, France

View Trial Details

Recruiting

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

NCT06287723

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
Locations: CHU de Montpellier Montpellier, France

Institu régional du Cancer de Montpellier (ICM) Montpellier, France

View Trial Details

Recruiting

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

NCT03326921

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT05735717

Conditions: AML, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Recruiting

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

NCT07291921

Conditions: Immunotherapy, Lung Diseases, Lung Neoplasms, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Caris Biorepository Research Protocol

NCT01499394

Conditions: Cancer, Early Detection of Cancer, Minimal Residual Disease, +5 more
Locations: University of South Alabama Mobile, Alabama, United States

Southwest Medical Imaging Scottsdale, Arizona, United States

St. Bernards Medical Center Jonesboro, Arkansas, United States

CARTI Cancer Center Little Rock, Arkansas, United States

View all 38 locations

View Trial Details

Recruiting

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

NCT06287749

Conditions: CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
Locations: CHU de Montpellier Montpellier, Hérault, France

View Trial Details

Recruiting

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

NCT05959720

Conditions: Acute Lymphoid Leukemia, Chemotherapeutic Toxicity, Gene Abnormality, +16 more
Locations: Instituto do Cancer do Estado de Sao Paulo São Paulo, Brazil

View Trial Details

Recruiting

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

NCT06930807

Conditions: Adaptive Treatment, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Minimal Residual Disease

Minimal Residual Disease trial results

Related conditions